Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings

Journal of Hepatology

Volumn 48, Issue 2, 2008, Pages 237-245

  Seki, Ekihiro ^a,b   Kondo, Yuichi ^a   Iimuro, Yuji ^a   Naka, Tetsuji ^c   Son, Gakuhei ^a   Kishimoto, Tadamitsu ^c   Fujimoto, Jiro ^a   Tsutsui, Hiroko ^a   Nakanishi, Kenji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; ERK1 2; Hepatocyte; SOCS1; SOCS3

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 6; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; LIVER CELL; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; DNA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEPATOCYTES; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 37849018468     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.08.020     Document Type: Article

References (40)

1. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5 (2004) 836-847
2. Fausto N., and Riehle K.J. Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg 2 (2005) 181-189
3. Michalopoulos G.K., and Khan Z. Liver regeneration, growth factors, and amphiregulin. Gastroenterolology 128 (2005) 503-506
4. Seki E., Tsutsui H., Iimuro Y., Naka T., Son G., Akira S., et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41 (2005) 443-450
5. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol 23 (2005) 1-21
6. Streetz K.L., Luedde T., Manns M.P., and Trautwein C. Interleukin 6 and liver regeneration. Gut 47 (2000) 309-312
7. Stolz D.B., Mars W.M., Petersen B.E., Kim T.-H., and Michalopoulos G.K. Growth factor signal transduction immediately after two-thirds partial hepatectomy in rat. Cancer Res 59 (1999) 3954-3960
8. Wuestefeld T., Klein C., Stretz K.L., Bertz U., Lauber J., Buer J., et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278 (2003) 11281-11288
9. Li W., Liang X., Kellendonk C., Poli V., and Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277 (2002) 28411-28417
10. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387 (1997) 924-929
11. Starr R., Willson T.A., Viney E.M., Murray L.J.L., Rayner J.R., Jenkins B.J., et al. A family of cytokine-inducible inhibitors of signaling. Nature 387 (1997) 917-921
12. Endo T.A., Masahara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 (1997) 921-924
13. Kubo M., Hanada T., and Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 4 (2003) 1169-1176
14. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling proteins in regulation of the immune response. Annu Rev Immunol 22 (2004) 503-529
15. Naka T., Fujimoto M., Tsutsui H., and Yoshimura A. Negative regulation of cytokine and TLR signalings by SOCS and others. Adv Immunol 87 (2005) 61-122
16. Yoshimura A., Nishinakamura H., Matsumura Y., and Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 7 (2005) 100-110
17. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4 (2003) 551-556
18. Croker B.A., Krebs D.L., Zhang J.-G., Wormald S., Willson T.A., Stanley E.G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4 (2003) 540-545
19. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
20. Zhong Z., Wen Z., and Darnell J.E.J. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264 (1994) 95-98
21. Baccaccio C., Andò M., Tamagnone L., Bardelli A., Michieli P., Battistini C., et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391M (1998) 285-288
22. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101 (1998) 802-811
23. Adachi K., Tsutsui H., Kashiwamura S., Seki E., Nakano H., Takeuchi O., et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 167 (2001) 5928-5934
24. Schwabe R.F., Bradham C.A., Uehara T., Hatano E., Bennett B.L., Schoonhoeven R., et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37 (2003) 824-832
25. Ogushi I., Iimuro Y., Seki E., Son G., Hirano T., Hada T., et al. Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology 38 (2003) 335-344
26. Lollo C.P., Banaszczyk M.G., Rill C., Coffin C.C., Lucas M.A., and Chiou H.C. Gene therapy strategies for the treatment of chronic viral hepatitis. Exp Opin Biol Ther 1 (2001) 629-639
27. Kermorgant S., and Parker P.J. c-Met signalling. Cell Cycle 4 (2005) 352-355
28. Tarnowski A.S. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 50 (2005) S24-S33
29. Pierce K.L., Luttrell L.M., and Lefkowitz R.J. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20 (2001) 1532-1539
30. Huh C.G., Factor V.M., Sanchez A., Uchida K., Conner E.A., and Thorgeirsson S.S. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101 (2004) 4477-4482
31. Borowiak M., Garratt A.N., Wustefeld T., Strehle M., Trautwein C., and Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 101 (2004) 10608-10613
32. Breuhahn K., Longerich T., and Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25 (2006) 3787-3800
33. Paranjpe S., Bowen W.C., Bell A.W., Nejak-Bowen K., Luo J.-H., and Michalopoulos G.K. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 45 (2007) 1471-1477
34. Tokumaru S., Sayama K., Yamasaki K., Shirakata T., Hanakawa Y., Yahata Y., et al. SOCS3/Cis3 negative regulation of STAT3 in HGF-induced keratinocyte migration. Biophys Biochem Res Commun 327 (2005) 100-105
35. Xia L., Wang L., Chung A.S., Ivanov S.S., Ling M.Y., Dragoi A.M., et al. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277 (2002) 30716-30723
36. Tokumaru S., Sayama K., Shirakata Y., Komatuzawa H., Ouhara K., Hanakawa Y., et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175 (2005) 4662-4668
37. Haga S., Ogawa W., Inoue H., Terui K., Ogino T., Igarashi R., et al. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol 43 (2005) 799-807
38. Shouda T., Yoshida T., Hanada T., Wakioka T., Oishi M., Miyoshi K., et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 108 (2001) 1781-1788
39. Yasukawa H., Yajima T., Duplain H., Iwatate M., Kido M., Hoshijima M., et al. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 111 (2003) 469-478
40. Jo D., Liu D., Yao S., Collins R.D., and Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Immunol 8 (2005) 892-898